Overview
Product name | Biotinylated Recombinant Human TNFRSF4/OX40/CD134 Protein (Primary Amine Labeling) |
---|
Catalog No. | RP00362BLQ |
---|
Description | Biotinylated Recombinant Human TNFRSF4/OX40/CD134 Protein (Primary Amine Labeling) is produced by HEK293 cells expression system. The target protein is expressed with sequence (Leu29-Ala216) of Human OX40/TNFRSF4/CD134 (Primary Amine Labeling) (Accession #P43489) fused with a C-hFc tag at the C-terminus. |
---|
Purity | > 95% by SDS-PAGE |
---|
Endotoxin | < 1 EU/μg of the protein by LAL method |
---|
Formulation | Supplied as 0.22 μm filtered solution in PBS (pH 7.4). |
---|
Species | Human |
---|
Calculated MW | 46.8 kDa |
---|
Background
Tumor necrosis factor receptor superfamily, member 4 (TNFRSF4), also known as CD134 and OX40 receptor. OX40 is a secondary co-stimulatory immune checkpoint molecule, expressed after 24 to 72 hours following activation; its ligand, OX40L, is also not expressed on resting antigen presenting cells, but is following their activation.
Product information
Synonym | CD134; OX40; OX40L receptor; TNFRSF4; ACT-135; Ly-70; OX40 homologue; TXGP1L; IMD16 |
---|
Expression Host | HEK293 cells |
---|
Tag | C-hFc |
---|
Swiss-Prot | |
---|
Gene ID | |
---|
Usage guide
Storage | Store at -70℃. This product is stable at ≤ -70℃ for up to 1 year from the date of receipt. For optimal storage, aliquot into smaller quantities after centrifugation and store at recommended temperature. Avoid repeated freeze-thaw cycles. |
---|
* For research use only. Not for therapeutic or diagnostic purposes.